Gene Editing Market
8 prime editing protocols entering human clinical trials in 2026 As 2026 begins, the global biotechnology landscape is shifting from traditional CRISPR methods toward more refined "search-and-replace" genetic tools that offer unprecedented precision in DNA repair. Recent clinical updates from research clusters in Cambridge and Shanghai indicate that these next-generation protocols are...
0 Comentários 0 Compartilhamentos 109 Visualizações 0 Anterior